Inactive Instrument

Company Grindeks

Equities

GRD1R

LV0000100659

Pharmaceuticals

Business Summary

Grindeks is the Baltic leader pharmaceutical group. Net sales break down by activity as follows:

- research, development and manufacturing of pharmaceuticals (94.9%): medicines for the treatment of cardiovascular diseases, cancers and central nervous system disorders, analgesic products, treatments of cough and flu, etc.;

- production of pharmaceutical active ingredients (5.1%).

Net sales break down geographically as follows: Latvia (6.6%), Russia (59.6%), Lithuania (4%), Estonia (1.7%) and other (28.1%).

Number of employees: 1,505

Managers

Managers TitleAgeSince
Chief Executive Officer 44 -
Director of Finance/CFO 64 02-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Corporate Officer/Principal 39 21-02-23
Sales & Marketing - -

Members of the board

Members of the board TitleAgeSince
Chairman 83 02-12-31
Director/Board Member 76 07-12-31
Director/Board Member 46 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,585,000 308,478 ( 3.218 %) 0 3.218 %

Company contact information

Grindeks AS

Krustpils iela 53

LV-1057, Riga

+

http://grindeks.eu
address Grindeks(GRD1R)